Targeted deletion of NFAT-Interacting-Protein-(NIP) 45 resolves experimental asthma by inhibiting Innate Lymphoid Cells group 2 (ILC2).


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 10 2019
Historique:
received: 23 05 2019
accepted: 02 10 2019
entrez: 1 11 2019
pubmed: 2 11 2019
medline: 30 10 2020
Statut: epublish

Résumé

Here we investigated the role of NFAT-interacting protein (NIP)-45, an Interleukin (IL)-4 inducing Transcription Factor, and its impact on the differentiation of Group 2 Innate -Lymphoid -Cells (ILC2s) in the pathogenesis of asthma. NIP45, a transcription factor regulating NFATc1 activity, mRNA was found to be induced in the Peripheral Blood mononuclear cells (PMBCs) of asthmatic pre-school children with allergies and in the peripheral blood CD4

Identifiants

pubmed: 31666531
doi: 10.1038/s41598-019-51690-z
pii: 10.1038/s41598-019-51690-z
pmc: PMC6821848
doi:

Substances chimiques

Carrier Proteins 0
Interleukin-33 0
NFATC Transcription Factors 0
NFATC1 protein, human 0
NFATC2IP protein, human 0
T-Box Domain Proteins 0
T-box transcription factor TBX21 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15695

Références

Cell. 2014 Apr 10;157(2):340-356
pubmed: 24725403
Nature. 2010 Apr 29;464(7293):1367-70
pubmed: 20200518
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3663-8
pubmed: 20133688
Clin Exp Allergy. 2015 Aug;45(8):1356-66
pubmed: 25640055
J Biol Chem. 2004 Aug 27;279(35):36210-8
pubmed: 15229217
Eur J Immunol. 2015 May;45(5):1426-40
pubmed: 25689841
Mol Cell Biol. 1999 Mar;19(3):2300-7
pubmed: 10022916
J Allergy Clin Immunol. 2016 Jun;137(6):1898-1902.e7
pubmed: 26993036
Science. 1996 Dec 13;274(5294):1903-5
pubmed: 8943202
Mucosal Immunol. 2019 Mar;12(2):299-311
pubmed: 30664706
Cell Commun Signal. 2012 Jul 05;10(1):16
pubmed: 22764736
Immunity. 2005 Nov;23(5):479-90
pubmed: 16286016
Nature. 2014 Apr 17;508(7496):397-401
pubmed: 24509713
Eur J Immunol. 2012 May;42(5):1106-16
pubmed: 22539286
J Leukoc Biol. 2011 Nov;90(5):867-74
pubmed: 21712394
Blood. 2010 Apr 15;115(15):2989-97
pubmed: 20103781
Stat Appl Genet Mol Biol. 2005;4:Article29
pubmed: 16646847
Ann Allergy Asthma Immunol. 2018 Jan;120(1):94-95
pubmed: 29162317
Immunity. 1998 Jan;8(1):115-24
pubmed: 9462517
J Immunol. 2008 Oct 1;181(7):4780-90
pubmed: 18802081
J Clin Invest. 2016 Sep 1;126(9):3185-7
pubmed: 27548525
Immunity. 1996 Apr;4(4):397-405
pubmed: 8612134
Nat Immunol. 2002 Jan;3(1):48-54
pubmed: 11740499
Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7175-80
pubmed: 17438271
Immunity. 2014 Sep 18;41(3):366-374
pubmed: 25238094
Immunity. 2012 Mar 23;36(3):451-63
pubmed: 22425247
J Exp Med. 2001 Jun 4;193(11):1247-60
pubmed: 11390432
Mucosal Immunol. 2016 Nov;9(6):1384-1394
pubmed: 26982595
Nat Immunol. 2018 Oct;19(10):1093-1099
pubmed: 30201992
Nat Med. 2012 May 04;18(5):684-92
pubmed: 22561832
Nature. 2016 Jan 14;529(7585):221-5
pubmed: 26675736
Eur J Immunol. 2007 Jun;37(6):1663-77
pubmed: 17506035
Nat Rev Immunol. 2003 May;3(5):405-12
pubmed: 12766762
Immunity. 1998 Jan;8(1):125-34
pubmed: 9462518
J Allergy Clin Immunol. 2012 Jan;129(1):191-8.e1-4
pubmed: 22079492
Mol Cell. 2004 Aug 27;15(4):559-71
pubmed: 15327772
J Immunol. 2008 Aug 1;181(3):1917-26
pubmed: 18641329
Mucosal Immunol. 2016 Sep;9(5):1183-92
pubmed: 26732679
Immunobiology. 2012 Sep;217(9):905-11
pubmed: 22317750
J Allergy Clin Immunol. 2011 Sep;128(3):549-56.e1-12
pubmed: 21752437
Immunity. 1997 Dec;7(6):849-60
pubmed: 9430230
Immunity. 2014 Mar 20;40(3):425-35
pubmed: 24613091
N Engl J Med. 1992 Jan 30;326(5):298-304
pubmed: 1530827
Nat Rev Immunol. 2005 Jun;5(6):472-84
pubmed: 15928679
J Mol Biol. 2004 Oct 1;342(5):1659-74
pubmed: 15364589
Science. 2018 Jan 5;359(6371):114-119
pubmed: 29302015

Auteurs

Sonja Koch (S)

Department of Molecular Pneumology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.

Lisa Knipfer (L)

Department of Medicine 1 - Gastroenterology, Pneumology and Endocrinology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.

Julia Kölle (J)

Department of Molecular Pneumology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.

Hooman Mirzakhani (H)

Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Anna Graser (A)

Department of Molecular Pneumology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.

Theodor Zimmermann (T)

Department of Pediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, Erlangen, Germany.

Alexander Kiefer (A)

Department of Pediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, Erlangen, Germany.

Volker O Melichar (VO)

Department of Pediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, Erlangen, Germany.

Wolfgang Rascher (W)

Department of Pediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, Erlangen, Germany.

Nikolaos G Papadopoulos (NG)

Allergy and Clinical Immunology Unit, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, 11527, Athens, Greece.
Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester, UK.

Ralf J Rieker (RJ)

Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Benjamin A Raby (BA)

Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Scott T Weiss (ST)

Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Stefan Wirtz (S)

Department of Medicine 1 - Gastroenterology, Pneumology and Endocrinology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.

Susetta Finotto (S)

Department of Molecular Pneumology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. susetta.finotto@uk-erlangen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH